Much to do about carbapenem-resistant enterobacteriaceae: Why supplementing surveillance may be the key to stopping spread

Infection Control and Hospital Epidemiology

Volumn 35, Issue 8, 2014, Pages 984-986

  Pfeiffer, Christopher D ^a,b   Beldavs, Zintars G ^c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AUTHORITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; BACTERIUM DETECTION; BLOOD CULTURE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CATHETER INFECTION; COMMUNITY HOSPITAL; DIAGNOSTIC TEST; DISEASE TRANSMISSION; HEALTH CARE; HEALTH SURVEY; INFECTION CONTROL; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MANDATORY TESTING; NONHUMAN; NOTE; PHENOTYPE; POLYMERASE CHAIN REACTION; PUBLIC HEALTH; CROSS INFECTION; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMAN; STATISTICS AND NUMERICAL DATA;

CARBAPENEM DERIVATIVE;

CARBAPENEMS; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HOSPITALS, COMMUNITY; HUMANS;

EID: 84904402905     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/677158     Document Type: Note

References (20)

1. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. http://www. cdc. gov/drugresistance/threat-report-2013/. Accessed April 29, 2014.
2. Centers for Disease Control and Prevention. Tracking CRE. http://www. cdc. gov/hai/organisms/cre/TrackingCRE. html. Accessed April 29, 2014.
3. Centers for Disease Control and Prevention. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 2013; 62(9): 165-170.
4. Thaden J, Lewis S, Hazen K, et al. Rising rates of carbapenem-resistant Enterobacteriaceae in community hospitals: a mixedmethods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States. Infect Control Hosp Epidemiol 2014; 35(8): 978-983 (in this issue).
5. Epson EE, Pisney LM, Wendt JM, et al. Carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-betalactamase at an acute care hospital, Colorado, 2012. Infect Control Hosp Epidemiol 2014; 35(4): 390-397.
6. Mathers AJ, Hazen KC, Carroll J, et al. First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world. J Clin Microbiol 2013; 51(2): 680-683.
7. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2012; 18(9): 1503-1507.
8. Vasoo S, Cunningham SA, Kohner PC, et al. Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modified Hodge test for detection of carbapenemaseproducing gram-negative bacilli. J Clin Microbiol 2013; 51(9): 3097-3101.
9. Tijet N, Boyd D, Patel SN, Mulvey MR, Melano RG. Evaluation of the Carba NP test for rapid detection of carbapenemaseproducing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother 2013; 57(9): 4578-4580.
10. BioFire Diagnostics. FilmArray blood culture identification panel. http://filmarray. com/the-panels/. Accessed April 29, 2014.
11. Nanosphere. Verigene gram-negative blood culture test. http://www. nanosphere. us/products/gram-negative-blood-culture-test. Accessed April 29, 2014.
12. Pfeiffer CD, Cunningham MC, Poissant T, et al. Establishment of a statewide network for carbapenem-resistant Enterobacteriaceae prevention in a low-incidence region. Infect Control Hosp Epidemiol 2014; 35(4): 356-361.
13. Extensively drug resistant organism (XDRO) registry. https://www. xdro. org/. Accessed April 29, 2014.
14. Verhoef J, Beaujean D, Blok H, et al. A Dutch approach to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1999; 18(7): 461-466.
15. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001; 344(19): 1427-1433.
16. Schwaber MJ, Carmeli Y. An ongoing national intervention to contain the spread of carbapenem-resistant Enterobacteriaceae. Clin Infect Dis 2014; 58(5): 697-703.
17. Schwaber MJ, Lev B, Israeli A, et al. Containment of a countrywide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011; 52(7): 848-855.
18. Brennan BM, Coyle JR, Marchaim D, et al. Statewide surveillance of carbapenem-resistant Enterobacteriaceae in Michigan. Infect Control Hosp Epidemiol 2014; 35(4): 342-349.
19. Won SY, Munoz-Price LS, Lolans K, et al. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemaseproducing Enterobacteriaceae. Clin Infect Dis 2011; 53(6): 532-540.
20. Lin MY, Lyles-Banks RD, Lolans K, et al. The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2013; 57(9): 1246-1252.